Back to news

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Globe Newswire•29/09/2026•08:00 ET
0

Key Highlights

  • ➤Renuvion (APYX) treatment increased elastin fiber density 30% at Day 180
  • ➤Renuvion (APYX) treatment reduced inflammation 34% versus untreated control tissue
  • ➤Renuvion (APYX) treatment increased elastin expression incidence 27% at Day 180
  • ➤100% of participants demonstrated physician- and patient-assessed aesthetic improvement
  • ➤Six participants completed Day 180 assessments in the prospective clinical study

Expert Statements

Charlie Goodwin, President and Chief Executive Officer of Apyx Medical Corporation

“These findings provide important new evidence supporting the biological basis for the clinical benefits observed with Renuvion. For years, surgeons have seen the clinical benefits of Renuvion in tissue contraction and have observed improvements in the quality of the overlying skin. This study provides direct human histological evidence supporting those observations, demonstrating meaningful changes in elastin and inflammation at the tissue level. We believe this research adds an important new dimension to the clinical understanding of Renuvion and its potential role in comprehensive aesthetic procedures. That is why we believe Renuvion should be part of every liposuction procedure, around the world. Liposuction addresses fat, but the quality of the tissue and skin left behind is also critical to the final result.”

CLEARWATER, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion(®) and the AYON Body Contouring System(™ )(AYON), today announced results from a prospective clinical study evaluating the effects of Renuvion helium plasma radiofrequency technology on biological markers of skin quality. The study was published in Plastic and Reconstructive Surgery—Global Open (1).

The study provides new human tissue evidence indicating that Renuvion treatment may produce measurable changes beneath the surface of the skin that support improvements in skin quality observed by physicians and participants.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in